Lyra Therapeutics, Inc. (LYRA)
OTCMKTS
· Delayed Price · Currency is USD
0.710
-0.040 (-5.33%)
At close: Apr 28, 2026
Lyra Therapeutics Employees
Lyra Therapeutics had 27 employees as of December 31, 2025. The number of employees decreased by 3 or -10.00% compared to the previous year.
Employees
27
Change (1Y)
-3
Growth (1Y)
-10.00%
Revenue / Employee
$14,741
Profits / Employee
-$1,071,074
Market Cap
1.25M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| LakeShore Biopharma | 573 |
| CERo Therapeutics Holdings | 8 |
| Abpro Holdings | 3 |
| Evofem Biosciences | 29 |
| Windtree Therapeutics | 14 |
| International Stem Cell | 33 |
Lyra Therapeutics News
- 12 days ago - Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC - GlobeNewsWire
- 3 months ago - Lyra Therapeutics Provides Corporate Update - GlobeNewsWire
- 6 months ago - Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study - GlobeNewsWire
- 9 months ago - Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 10 months ago - Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 11 months ago - Lyra Therapeutics Transcript: Study Result - Transcripts
- 11 months ago - Why Is Lyra Therapeutics Stock Surging Over 400% On Monday? - Benzinga